Artivion, Inc.
Status: Publicly traded
Direct answer
Artivion, Inc. is publicly traded on NYSE under the ticker AORT.
Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine pericardial patch, in...
Can you invest in Artivion, Inc.?
Yes. Artivion, Inc. trades publicly on NYSE as AORT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Artivion, Inc.
Detailed equity research is provided by MarketSnap.